Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMC Pharma, LLC is a specialty pharmaceutical company dedicated to the development, commercialization, and distribution of high-quality prescription and over-the-counter (OTC) medications. Headquartered in the United States, the company focuses on therapeutic areas including dermatology, ophthalmology, and wound care. EMC Pharma is well-known for its strategic partnerships, notably with Sonoma Pharmaceuticals, to market stabilized hypochlorous acid (HOCl) products such as Acuicyn and Ocucyn. Its portfolio also features advanced skincare solutions like the Rejuvala peptide collection and LaserSense post-procedure recovery products. The company leverages a global network of developers and manufacturers to provide cost-effective therapeutic options to the healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMC.